Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Concentrix Corporation. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Concentrix Corporation (CNXC) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Concentrix Corporation (NASDAQ: CNXC).
On June 29, 2026, Concentrix reported its financial results for the second quarter of its 2026 fiscal year. Among other items, Concentrix reduced its revenue and adjusted earnings forecasts, citing faster offshoring and customer spending reductions. On this news, Concentrix’s stock price fell $2.82 per share, or 11.18%, to close at $22.41 per share on 30, 2026. Then, on September 29, 2026, Concentrix again lowered its revenue outlook and disclosed a $1.05 billion noncash goodwill impairment, primarily attributed to its stock’s trading range and market capitalization. Together with its fiscal 2025 impairment, the charges totaled approximately $2.57 billion.
What Potential Securities Violations Is BG&G Investigating?
- Whether Concentrix Corporation and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Concentrix Corporation failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Concentrix Corporation (CNXC) Investors Do?
How Is Concentrix Corporation (NASDAQ: CNXC) Stock Trading Today?
Interactive chart showing the weekly share price history of NASDAQ:CNXC (NASDAQ:CNXC).
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”